<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Selected high-risk drugs</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Selected high-risk drugs</h1>
<div class="graphic"><div class="figure"><div class="ttl">Selected high-risk drugs</div><div class="cntnt"><table cellspacing="0"><colgroup span="2" width="20%"></colgroup><colgroup width="60%"></colgroup> <tbody> <tr> <td class="subtitle1">Drug</td> <td class="subtitle1">Potential harm</td> <td class="subtitle1">Comment</td> </tr> <tr> <td>Insulin</td> <td>Hypoglycemia</td> <td>May often be appropriate; however, aggressive glycemic control may often yield greater harms than benefits in older adults.<sup>[1-3]</sup></td> </tr> <tr> <td>Sulfonylureas</td> <td>Hypoglycemia</td> <td>Older hospitalized patients at significant risk for hypogylcemia; avoid or use with great caution.<sup>[4]</sup></td> </tr> <tr> <td>Warfarin</td> <td>Gastrointestinal, intracranial bleeding</td> <td>Although a high-risk drug, benefits of warfarin therapy often outweigh harms; maintenance of prothrombin time/international normalized ratio (INR) in therapeutic range tightly linked to risk/benefit ratio.<sup>[5]</sup></td> </tr> <tr> <td>Digoxin</td> <td>Impairment of cognition, heart block</td> <td>May have a third-line role in management of systolic heart failure; suboptimal choice for rate control in atrial fibrillation.</td> </tr> <tr> <td>Benzodiazepines</td> <td>Falls</td> <td>Associated with as much as a 60% increase in fall risk.<sup>[6]</sup></td> </tr> <tr> <td>Diphenhydramine, other first-generation antihistamines</td> <td>Impaired cognition, urinary retention in men</td> <td>Poor choice as sleep aid due to anticholinergic effects, next-day sedation, impact on performance including driving; close medication reconciliation important because patients may also obtain over-the-counter drugs.</td> </tr> <tr> <td>Opioid analgesics</td> <td>Constipation, sedation, confusion, cardiorespiratory depression, seizures</td> <td>Codeine, meperidine, pentazocine, butorphanol, and nalbuphine are poor choices for analgesia. Fentanyl, morphine, or oxycodone are often appropriate with careful dose adjustment.</td> </tr> <tr> <td>Antipsychotics</td> <td>Death, pneumonia</td> <td>Elevated risk of death when used to treat behavioral complications of dementia, although, in selected cases, benefits may exceed risks if consistent with patient goals of care.<sup>[7]</sup></td> </tr> <tr> <td>Chemotherapeutic agents</td> <td>Myelosuppression (neutropenia, anemia), hepatotoxicity, cardiotoxicity</td> <td>Comprehensive assessment is required for determining goals of treatment, particularly in light of comorbidities. When indicated, chemotherapy dose and schedule should be carefully individualized for organ function and anticipated toxicities of treatment. In general, greater treatment-related toxicity is accepted when the expected outcome of treatment is cure.</td> </tr> <tr> <td class="subtitle2_left" colspan="3">Selected antimicrobials</td> </tr> <tr> <td class="indent1">Fluoroquinolones</td> <td>Tendon inflammation and rupture, hypoglycemia, cardiac arrhythmias, <em>Clostridioides</em> <em>difficile</em>-associated diarrhea, exacerbation of myasthenia gravis</td> <td>Elevated risk of tendon rupture in combination with glucocorticoids.</td> </tr> <tr> <td class="indent1">Nitrofurantoin</td> <td>In chronic use (rarely): Pulmonary fibrosis, neuropathy, hepatotoxicity</td> <td>Avoid in older adults with creatinine clearance &lt;30 mL/minute; does not reach therapeutic concentrations in urine and increased risk of toxicity.</td> </tr> <tr> <td class="indent1">Trimethoprim-sulfamethoxazole (co-trimoxazole)</td> <td>Hyperkalemia, hypoglycemia (with sulfonylurea), severe dermatologic reaction (rare)</td> <td>Drug interactions include warfarin (↑ INR), agents that increase serum potassium, and sulfonylureas (↑ hypoglycemic effect).</td> </tr> </tbody></table></div><div class="graphic_reference">References: 

<ol>
<li>Brown AF, Mangione CM, Saliba D, Sarkisian CA. California Healthcare Foundation/American Geriatrics Society panel on improving care for elders with diabetes. Guidelines for improving the care of the older person with diabetes mellitus. J Am Geriatr Soc 2003; 51:S265. </li>
<li>Greenfield S, Billimek J, Pellegrini F, et al. Comorbidity affects the relationship between glycemic control and cardiovascular outcomes in diabetes. Ann Intern Med 2009; 151:854. </li>
<li>Gerstein HC, Miller ME, Byington RP, et al. Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008; 358:2545. </li>
<li>Deusenberry CM, Coley KC, Korytkowski MT, et al. Hypoglycemia in hospitalized patients treated with sulfonylureas. Pharmacotherapy 2012; 32:613.</li>
<li>Mant J, Hobbs FD, Fletcher K, et al. BAFTA investigators; Midland Research Practices Network (MidReC). Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA). Lancet 2007; 370:493. </li>
<li>Woolcott JC, Richardson KJ, Wiens MO, et al. Meta-analysis of the impact of 9 medication classes on falls in elderly persons. Arch Intern Med 2009; 169:1952. </li>
<li>Schneider LS, Dagerman KS, Insel P. Risk of death with atypical antipsychotic drug treatment for dementia. JAMA 2005; 294:1934. </li>
<li>American Geriatrics Society 2015 Beers Criteria Update Expert Panel. American Geriatrics Society 2015 updated Beers Criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc 2015;63:2227.</li></ol>Revisions and additional information included with data from: Steinman MA, Hanlon JT. Managing medications in clinically complex elders: "There's got to be a happy medium." JAMA 2010; 304:1592.</div><div id="graphicVersion">Graphic 51353 Version 14.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
